“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model

€3.03

SKU: product-article-21147 Category: General

Description
Reviews (0)

Description

O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model

Reviews

There are no reviews yet.

Be the first to review “Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model”

You must be logged in to post a review.

Top

Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in breast cancer

1 year access Online Belgian Journal of Hematology (BJH)